Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Saved in:
| Title: | Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma. |
|---|---|
| Authors: | Spurgeon SE; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA., Sharma K; Penn State Hershey Cancer Institute, Hershey, PA, USA.; Cassidy Cancer Center, Winter Haven, FL, USA., Claxton DF; Penn State Hershey Cancer Institute, Hershey, PA, USA., Ehmann C; Penn State Hershey Cancer Institute, Hershey, PA, USA., Pu J; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA., Shimko S; Penn State Hershey Cancer Institute, Hershey, PA, USA., Stewart A; Penn State Hershey Cancer Institute, Hershey, PA, USA., Subbiah N; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA., Palmbach G; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA., LeBlanc F; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Latour E; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Chen Y; Biostatistics Shared Resource, Oregon Health and Science University, Portland, OR, USA., Mori M; Biostatistics Shared Resource, Oregon Health and Science University, Portland, OR, USA., Hasanali Z; Penn State Hershey Cancer Institute, Hershey, PA, USA., Epner EM; Penn State Hershey Cancer Institute, Hershey, PA, USA.; Enloe Medical Center, Chico, CA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2019 Sep; Vol. 186 (6), pp. 845-854. Date of Electronic Publication: 2019 Jun 09. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31177537 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spurgeon+SE%22">Spurgeon SE</searchLink>; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Sharma+K%22">Sharma K</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.; Cassidy Cancer Center, Winter Haven, FL, USA.<br /><searchLink fieldCode="AU" term="%22Claxton+DF%22">Claxton DF</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ehmann+C%22">Ehmann C</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pu+J%22">Pu J</searchLink>; Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA.<br /><searchLink fieldCode="AU" term="%22Shimko+S%22">Shimko S</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+A%22">Stewart A</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+N%22">Subbiah N</searchLink>; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Palmbach+G%22">Palmbach G</searchLink>; Center for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22LeBlanc+F%22">LeBlanc F</searchLink>; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Latour+E%22">Latour E</searchLink>; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Biostatistics Shared Resource, Oregon Health and Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Mori+M%22">Mori M</searchLink>; Biostatistics Shared Resource, Oregon Health and Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hasanali+Z%22">Hasanali Z</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Epner+EM%22">Epner EM</searchLink>; Penn State Hershey Cancer Institute, Hershey, PA, USA.; Enloe Medical Center, Chico, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2019 Sep; Vol. 186 (6), pp. 845-854. <i>Date of Electronic Publication: </i>2019 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31177537 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.16008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 845 Titles: – TitleFull: Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spurgeon SE – PersonEntity: Name: NameFull: Sharma K – PersonEntity: Name: NameFull: Claxton DF – PersonEntity: Name: NameFull: Ehmann C – PersonEntity: Name: NameFull: Pu J – PersonEntity: Name: NameFull: Shimko S – PersonEntity: Name: NameFull: Stewart A – PersonEntity: Name: NameFull: Subbiah N – PersonEntity: Name: NameFull: Palmbach G – PersonEntity: Name: NameFull: LeBlanc F – PersonEntity: Name: NameFull: Latour E – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Mori M – PersonEntity: Name: NameFull: Hasanali Z – PersonEntity: Name: NameFull: Epner EM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2019 Sep Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 186 – Type: issue Value: 6 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |